ANI Pharmaceuticals Stock Forecast

Stock Price Forecast

The 6 analysts with 12-month price forecasts for ANI Pharmaceuticals stock have an average target of 107.33, with a low estimate of 90 and a high estimate of 124. The average target predicts an increase of 42.08% from the current stock price of 75.54.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$90	$107.33	$115	$124
Change	+19.14%	+42.08%	+52.24%	+64.15%

* Price targets were last updated on Jan 16, 2026.

Analyst Ratings

The average analyst rating for ANI Pharmaceuticals stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	4	4	3	3	3	3
Buy	3	2	3	2	2	2
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	8	7	7	6	6	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Vamil Divan Guggenheim	Guggenheim	Strong Buy Maintains $115 → $124	Strong Buy	Maintains	$115 → $124	+64.15%	Jan 16, 2026
Glen Santangelo Barclays	Barclays	Buy Initiates $100	Buy	Initiates	$100	+32.38%	Dec 9, 2025
Vamil Divan Guggenheim	Guggenheim	Strong Buy Maintains $114 → $115	Strong Buy	Maintains	$114 → $115	+52.24%	Nov 10, 2025
Gregory Fraser Truist Securities	Truist Securities	Hold Maintains $77 → $90	Hold	Maintains	$77 → $90	+19.14%	Oct 9, 2025
Ekaterina Knyazkova JP Morgan	JP Morgan	Buy Maintains $95 → $115	Buy	Maintains	$95 → $115	+52.24%	Sep 24, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

1.06B

from 883.37M

19.88%

from 883.37M

Revenue Next Year

1.23B

from 1.06B

15.77%

from 1.06B

EPS This Year

9.09

from 3.32

173.56%

from 3.32

EPS Next Year

10.82

from 9.09

19.00%

from 9.09

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	216.14M	316.39M	486.82M	614.38M	883.37M	1.06B	1.23B
Revenue Growth	3.68%	46.38%	53.87%	26.20%	43.78%	19.88%	15.77%
EPS	-3.40	-3.05	0.85	-1.04	3.32	9.09	10.82
EPS Growth	-	-	-	-	-	173.56%	19.00%
Forward PE	-	-	-	-	-	8.31	6.98
No. Analysts	-	-	-	-	-	10	8

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	1.2B	1.3B
Avg	1.1B	1.2B
Low	910.9M	1.1B

Revenue Growth

Revenue Growth	2026	2027
High	30.9%	24.8%
Avg	19.9%	15.8%
Low	3.1%	5.5%

EPS Forecast

EPS	2026	2027
High	10.21	12.74
Avg	9.09	10.82
Low	7.45	9.09

EPS Growth

EPS Growth	2026	2027
High	207.2%	40.1%
Avg	173.6%	19.0%
Low	124.0%	0.0%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.